The STatus Epilepticus Prognosis Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The STatus Epilepticus Prognosis Study — Stella

Home/Status Epilepticus/

View on ClinicalTrials.gov

Recruiting

Back to Status Epilepticus trials

Trial locations(1 site)

Canada

Lawson Health Research Institute, London, Ontario

Key details

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Enrollment target

~50 participants

Started

November 2022

Primary completion

December 2026

Age range

18 Years – 80 Years

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.